U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
- Written by PR Newswire
![]() |
Medtronic moves for patent infringement litigation to resume
DUBLIN, March 22, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed the validity of claims in two of its patents in an ongoing patent...
Read more: U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents















